Myristoyl-CoA analog B13 and its derivative LCL204 are inhibitors of NMT1 activity and Src myristoylation and compete for myristoyl-CoA binding sites, effectively inhibiting Src family kinase-mediated cancer [185]. The gene discussed is NMT1; the disease is cancer.